Clinicopathological Spectrum of Breast Cancer Patients Presenting at a Tertiary Care Hospital in Sindh, Pakistan
Sara Khalid Memon, Faiza Hameed, Nawaz A Dal, Mahak W Qureshi, Qambar A Laghari

TL;DR
This study examines the clinicopathological features of breast cancer patients in Pakistan to aid in early diagnosis and management.
Contribution
The study provides region-specific insights into breast cancer characteristics in Sindh, Pakistan.
Findings
Most patients had intraductal carcinoma and grade III tumors.
Triple-negative breast cancer was observed in 19% of patients.
Nipple retraction and palpable axillary lymph nodes were common clinical signs.
Abstract
Objective The objective of this study was to evaluate the various clinicopathological characteristics of breast cancer patients presenting at the Department of Surgery at Liaquat University Hospital, Jamshoro. Study design and setting A cross-sectional analytical study was conducted at the Department of Surgery, Liaquat University Hospital, Jamshoro, Pakistan, from 1 November 2024 to 30 April 2025. Methodology With a population size of around 150 patients, a margin of error of 10%, and a CI of 99%, 79 patients were asked to fill out a structured questionnaire using a consecutive sampling technique. Data were analyzed using SPSS version 16 (SPSS Inc., Chicago, IL, USA). The frequency of various clinicopathological characteristics was measured using descriptive analytics. Results A total of 79 patients were included, with a mean age of 41.94±10.85. Most women were married for more…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBreast Cancer Treatment Studies · Breast Lesions and Carcinomas · HER2/EGFR in Cancer Research
